Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Recruiting · NCT04789148 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency | Diabetes Insipidus, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, anxiety disorder, brain disorder, central nervous system disorder, depressive disorder, diabetes insipidus, endocrine system disorder, hypopituitarism, hypothalamic disorder, kidney disorder, nervous system disorder, pituitary gland disorder, psychiatric disorder, urinary system disorder | Recruiting | Phase 1 | 2026-07-23 | NCT04789148 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elizabeth Austen Lawson | 2 |
| Tonix Pharmaceuticals, Inc. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital, Neuroendocrine Unit | Boston | United States | 1 |